RADIOMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RADIOMED
Largest movements
- Receivables within one year -€26,778
down €26,778 (-2.7%), from €987,299 to €960,521
- Cash +€25,027
up €25,027 (+1,104%), from €2,266 to €27,293
mainly Receivables within one year (+€26,778) and Net result for the year (+€17,836)
- Trade debts -€19,587
no longer reported in 2025 (was €19,587)
- Profit (loss) carried forward +€17,836
up €17,836 (+2.0%), from €905,718 to €923,554
- Financial income -€46,849
down €46,849 (-71.1%), from €65,885 to €19,036
of which Non-recurring financial income: -€47,014
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €989,565 | €987,814 | -€1,751 | -0.2% |
| Current assets | 29/58 | €989,565 | €987,814 | -€1,751 | -0.2% |
| Amounts receivable within one year | 40/41 | €987,299 | €960,521 | -€26,778 | -2.7% |
| Other amounts receivable | 41 | €987,299 | €960,521 | -€26,778 | -2.7% |
| Cash at bank and in hand | 54/58 | €2,266 | €27,293 | +€25,027 | +1,104% |
| Total equity and liabilities | 10/49 | €989,565 | €987,814 | -€1,751 | -0.2% |
| Equity | 10/15 | €969,978 | €987,814 | +€17,836 | +1.8% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Capital | 10 | €12,400 | €12,400 | = | 0.0% |
| Issued capital | 100 | €18,600 | €18,600 | = | 0.0% |
| Uncalled capital | 101 | €6,200 | €6,200 | = | 0.0% |
| Reserves | 13 | €51,860 | €51,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Legal reserve | 130 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €50,000 | €50,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €905,718 | €923,554 | +€17,836 | +2.0% |
| Amounts payable | 17/49 | €19,587 | - | -€19,587 | |
| Amounts payable within one year | 42/48 | €19,587 | - | -€19,587 | |
| Trade debts | 44 | €19,587 | - | -€19,587 | |
| Suppliers | 440/4 | €19,587 | - | -€19,587 | |
| Non-recurring operating charges | 66A | €340 | €840 | +€500 | +147% |
| Operating profit (loss) | 9901 | -€340 | -€840 | -€500 | -147% |
| Financial income | 75/76B | €65,885 | €19,036 | -€46,849 | -71.1% |
| Recurring financial income | 75 | €18,871 | €19,036 | +€165 | +0.9% |
| Non-recurring financial income | 76B | €47,014 | - | -€47,014 | |
| Financial charges | 65/66B | €2,199 | €360 | -€1,839 | -83.6% |
| Recurring financial charges | 65 | €2,199 | €360 | -€1,839 | -83.6% |
| Profit (loss) for the period before taxes | 9903 | €63,346 | €17,836 | -€45,510 | -71.8% |
| Income taxes | 67/77 | €2,222 | - | -€2,222 | |
| Profit (loss) for the period | 9904 | €61,124 | €17,836 | -€43,288 | -70.8% |
| Profit (loss) for the period to be appropriated | 9905 | €61,124 | €17,836 | -€43,288 | -70.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.